South Kerrier PCN Pharmacy Team: Audit Tool for DOAC Prescribing in General Practice

An audit tool was developed to help review direct oral anti-coagulant (DOAC) prescribing in general practice. The tool rapidly ascertains whether a patient is prescribed the correct dose of DOAC (apixaban, dabigatran, edoxaban or rivaroxaban) for the indication (AF or DVT/PE treatment or prophylaxis) based on duration, renal function and other demographic properties, with reference to manufacturers’ recommendations. If the patient is not being treated with the correct dose (or if unclear), some direction as to the necessary review is usually provided. Data collection and initial analysis has been reduced from several hours to about five minutes.

The judges felt the project was a strong one which was well presented with a patient safety focus that is already reaching national attention. It is easily replicable with very little financial investment and can be made available nationally through NHS Futures.

To read this entry in full visit HSJ Solutions.


NHS Kent and Medway and Kent Community Health FT: East Kent Targeted High Dose Opioid Reduction Project — HIGHLY COMMENDED

Buckinghamshire, Oxfordshire and Berkshire West ICB: Reducing the Prescribing of Oral Methotrexate 10mg tablet

Cheshire and Merseyside ICB – Sefton: Delivery of Medicines Optimisation to Improve Patient Safety

East London FT: Pharmacy Input into District Nursing Teams

Hampshire Hospitals FT: In the NAC of Time: Reducing Length of Stay, Freeing up Inpatient Beds With SNAP 12hr Paracetamol Overdose Regime

Kent and Medway ICB and Aspire Medical Health: Risk Stratification in Primary Care

Southern Health and Social Care Trust: Improving Medicines Administration in Gillis Memory Centre


Winners of HSJ Patient Safety Awards 2022 revealed